127 related articles for article (PubMed ID: 18829751)
1. Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.
Yuste E; Bixby J; Lifson J; Sato S; Johnson W; Desrosiers R
J Virol; 2008 Dec; 82(24):12472-86. PubMed ID: 18829751
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus.
Martinez-Navio JM; Desrosiers RC
J Virol; 2012 Dec; 86(23):12484-93. PubMed ID: 22993152
[TBL] [Abstract][Full Text] [Related]
3. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
Burns DP; Collignon C; Desrosiers RC
J Virol; 1993 Jul; 67(7):4104-13. PubMed ID: 8510218
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.
Kodama T; Burns DP; Silva DP; Veronese FD; Desrosiers RC
J Virol; 1991 Apr; 65(4):2010-8. PubMed ID: 1705994
[TBL] [Abstract][Full Text] [Related]
5. Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.
Postler TS; Martinez-Navio JM; Yuste E; Desrosiers RC
J Virol; 2012 Jan; 86(2):1145-57. PubMed ID: 22072749
[TBL] [Abstract][Full Text] [Related]
6. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
Chackerian B; Rudensey LM; Overbaugh J
J Virol; 1997 Oct; 71(10):7719-27. PubMed ID: 9311856
[TBL] [Abstract][Full Text] [Related]
7. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.
Johnson WE; Sanford H; Schwall L; Burton DR; Parren PW; Robinson JE; Desrosiers RC
J Virol; 2003 Sep; 77(18):9993-10003. PubMed ID: 12941910
[TBL] [Abstract][Full Text] [Related]
8. Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication.
Johnson WE; Sauvron JM; Desrosiers RC
J Virol; 2001 Dec; 75(23):11426-36. PubMed ID: 11689624
[TBL] [Abstract][Full Text] [Related]
9. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.
Cheng-Mayer C; Brown A; Harouse J; Luciw PA; Mayer AJ
J Virol; 1999 Jul; 73(7):5294-300. PubMed ID: 10364275
[TBL] [Abstract][Full Text] [Related]
10. Impact of glycosylation on antigenicity of simian immunodeficiency virus SIV239: induction of rapid V1/V2-specific non-neutralizing antibody and delayed neutralizing antibody following infection with an attenuated deglycosylated mutant.
Sugimoto C; Nakayama EE; Shioda T; Villinger F; Ansari AA; Yamamoto N; Suzuki Y; Nagai Y; Mori K
J Gen Virol; 2008 Feb; 89(Pt 2):554-566. PubMed ID: 18198387
[TBL] [Abstract][Full Text] [Related]
11. Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys.
Yeh WW; Brassard LM; Miller CA; Basavapathruni A; Zhang J; Rao SS; Nabel GJ; Mascola JR; Letvin NL; Seaman MS
J Virol; 2012 Jul; 86(13):7052-9. PubMed ID: 22532675
[TBL] [Abstract][Full Text] [Related]
12. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
[TBL] [Abstract][Full Text] [Related]
13. Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein.
Jurkiewicz E; Hunsmann G; Schäffner J; Nisslein T; Lüke W; Petry H
J Virol; 1997 Dec; 71(12):9475-81. PubMed ID: 9371609
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239.
Alexander L; Denekamp L; Czajak S; Desrosiers RC
J Virol; 2001 Apr; 75(8):4019-22. PubMed ID: 11264395
[TBL] [Abstract][Full Text] [Related]
15. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.
Burns DP; Desrosiers RC
Curr Top Microbiol Immunol; 1994; 188():185-219. PubMed ID: 7523031
[TBL] [Abstract][Full Text] [Related]
16. A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.
Kuwata T; Byrum R; Whitted S; Goeken R; Buckler-White A; Plishka R; Iyengar R; Hirsch VM
J Virol; 2007 Sep; 81(17):8891-904. PubMed ID: 17596304
[TBL] [Abstract][Full Text] [Related]
17. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
[TBL] [Abstract][Full Text] [Related]
18. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
Meyer D; Anderson DE; Gardner MB; Torres JV
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring V1-env region variants mediate simian immunodeficiency virus SIVmac escape from high-titer neutralizing antibodies induced by a protective subunit vaccine.
Petry H; Pekrun K; Hunsmann G; Jurkiewicz E; Lüke W
J Virol; 2000 Dec; 74(23):11145-52. PubMed ID: 11070011
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
